The SARIFA biomarker in the context of basic research of lipid-driven cancers
B Märkl, NG Reitsam, P Grochowski… - NPJ Precision …, 2024 - nature.com
SARIFA was very recently introduced as a histomorphological biomarker with strong
prognostic power for colorectal, gastric, prostate, and pancreatic cancer. It is characterized …
prognostic power for colorectal, gastric, prostate, and pancreatic cancer. It is characterized …
[HTML][HTML] Artificial intelligence in colorectal cancer: from patient screening over tailoring treatment decisions to identification of novel biomarkers
Background: Artificial intelligence (AI) is increasingly entering and transforming not only
medical research but also clinical practice. In the last 10 years, new AI methods have …
medical research but also clinical practice. In the last 10 years, new AI methods have …
Converging deep learning and human-observed tumor-adipocyte interaction as a biomarker in colorectal cancer
NG Reitsam, B Grosser, DF Steiner… - Communications …, 2024 - nature.com
Abstract Background Tumor-Adipose-Feature (TAF) as well as SARIFA (Stroma AReactive
Invasion Front Areas) are two histologic features/biomarkers linking tumor-associated …
Invasion Front Areas) are two histologic features/biomarkers linking tumor-associated …
Artificial Intelligence and Lung Pathology
This manuscript provides a comprehensive overview of the application of artificial
intelligence (AI) in lung pathology, particularly in the diagnosis of lung cancer. It discusses …
intelligence (AI) in lung pathology, particularly in the diagnosis of lung cancer. It discusses …
A pathologist–AI collaboration framework for enhancing diagnostic accuracies and efficiencies
In pathology, the deployment of artificial intelligence (AI) in clinical settings is constrained by
limitations in data collection and in model transparency and interpretability. Here we …
limitations in data collection and in model transparency and interpretability. Here we …
The relationship between Stroma AReactive Invasion Front Areas (SARIFA), Warburg-subtype and survival: results from a large prospective series of colorectal cancer …
K Offermans, NG Reitsam, CCJM Simons… - Cancer & …, 2024 - Springer
Abstract Background Stroma AReactive Invasion Front Areas (SARIFA) is a recently
identified haematoxylin & eosin (H&E) based histopathologic biomarker in gastrointestinal …
identified haematoxylin & eosin (H&E) based histopathologic biomarker in gastrointestinal …
SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict …
JS Enke, M Groß, B Grosser, E Sipos, J Steinestel… - BMC cancer, 2024 - Springer
Abstract Background Recently, we introduced Stroma-AReactive-Invasion-Front-Areas
(SARIFA) as a novel hematoxylin–eosin (H&E)-based histopathologic prognostic biomarker …
(SARIFA) as a novel hematoxylin–eosin (H&E)-based histopathologic prognostic biomarker …
[HTML][HTML] Predicting lymph node metastasis in colorectal cancer: An analysis of influencing factors to develop a risk model
YP Lei, QZ Song, S Liu, JY Xie… - World Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Colorectal cancer (CRC) is a significant global health issue, and lymph
node metastasis (LNM) is a crucial prognostic factor. Accurate prediction of LNM is essential …
node metastasis (LNM) is a crucial prognostic factor. Accurate prediction of LNM is essential …
Machine learning and deep learning models for preoperative detection of lymph node metastasis in colorectal cancer: a systematic review and meta-analysis
Objective To evaluate the diagnostic performance of Machine Learning (ML) and Deep
Learning (DL) models for predicting preoperative Lymph Node Metastasis (LNM) in …
Learning (DL) models for predicting preoperative Lymph Node Metastasis (LNM) in …
[HTML][HTML] Lymph Node Metastasis in Gastrointestinal Carcinomas: A View from a Proteomics Perspective
V Jain, P Sakhuja, AK Agarwal, R Sirdeshmukh… - Current …, 2024 - mdpi.com
Lymph node metastasis (LNM) is one of the major prognostic factors in human
gastrointestinal carcinomas (GICs). The lymph node-positive patients have poorer survival …
gastrointestinal carcinomas (GICs). The lymph node-positive patients have poorer survival …